IL-23-independent induction of IL-17 from γδT cells and innate lymphoid cells promotes experimental intraocular neovascularization

Journal of Immunology

Volumn 190, Issue 4, 2013, Pages 1778-1787

  Hasegawa, Eiichi ^a,b,c   Sonoda, Koh Hei ^d   Shichita, Takashi ^a,b   Morita, Rimpei ^a,b   Sekiya, Takashi ^a,b   Kimura, Akihiro ^a,b   Oshima, Yuji ^c   Takeda, Atsunobu ^c   Yoshimura, Takeru ^c   Yoshida, Shigeo ^c   Ishibashi, Tatsuro ^c   Yoshimura, Akihiko ^a,b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 23P19; MESSENGER RNA; THY 1 ANTIGEN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; GAMMA DELTA T LYMPHOCYTE; IN VITRO STUDY; INNATE LYMPHOID CELL; KNOCKOUT MOUSE; LYMPHOID CELL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SUBRETINAL NEOVASCULARIZATION; TH17 CELL; UPREGULATION;

ANIMALS; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; IMMUNITY, INNATE; INTERLEUKIN-17; INTERLEUKIN-23 SUBUNIT P19; LASERS; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84873543022     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202495     Document Type: Article

References (42)

1. Lim, L. S., P. Mitchell, J. M. Seddon, F. G. Holz, and T. Y. Wong. 2012. Agerelated macular degeneration. Lancet 379: 1728-1738.
2. Tuo, J., S. Grob, K. Zhang, and C. C. Chan. 2012. Genetics of immunological and inflammatory components in age-related macular degeneration. Ocul. Immunol. Inflamm. 20: 27-36.
3. Telander, D. G. 2011. Inflammation and age-related macular degeneration (AMD). Semin. Ophthalmol. 26: 192-197.
4. Grossniklaus, H. E., J. X. Ling, T. M. Wallace, S. Dithmar, D. H. Lawson, C. Cohen, V. M. Elner, S. G. Elner, and P. Sternberg, Jr. 2002. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol. Vis. 8: 119-126.
5. Tsutsumi, C., K. H. Sonoda, K. Egashira, H. Qiao, T. Hisatomi, S. Nakao, M. Ishibashi, I. F. Charo, T. Sakamoto, T. Murata, and T. Ishibashi. 2003. The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J. Leukoc. Biol. 74: 25-32.
6. Hijioka, K., K. H. Sonoda, C. Tsutsumi-Miyahara, T. Fujimoto, Y. Oshima, M. Taniguchi, and T. Ishibashi. 2008. Investigation of the role of CD1d-restricted invariant NKT cells in experimental choroidal neovascularization. Biochem. Biophys. Res. Commun. 374: 38-43.
7. Izumi-Nagai, K., N. Nagai, Y. Ozawa, M. Mihara, Y. Ohsugi, T. Kurihara, T. Koto, S. Satofuka, M. Inoue, K. Tsubota, et al. 2007. Interleukin-6 receptormediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization. Am. J. Pathol. 170: 2149-2158.
8. Lavalette, S., W. Raoul, M. Houssier, S. Camelo, O. Levy, B. Calippe, L. Jonet, F. Behar-Cohen, S. Chemtob, X. Guillonneau, et al. 2011. Interleukin-1b inhibition prevents choroidal neovascularization and does not exacerbate photoreceptor degeneration. Am. J. Pathol. 178: 2416-2423.
9. Hasegawa, E., Y. Oshima, A. Takeda, K. Saeki, H. Yoshida, K. H. Sonoda, and T. Ishibashi. 2012. IL-27 inhibits pathophysiological intraocular neovascularization due to laser burn. J. Leukoc. Biol. 91: 267-273.
10. Moran, E. M., M. Connolly, W. Gao, J. McCormick, U. Fearon, and D. J. Veale. 2011. Interleukin-17A induction of angiogenesis, cell migration, and cytoskeletal rearrangement. Arthritis Rheum. 63: 3263-3273.
11. Ryu, S., J. H. Lee, and S. I. Kim. 2006. IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes. Clin. Rheumatol. 25: 16-20.
12. Pickens, S. R., M. V. Volin, A. M. Mandelin, II, J. K. Kolls, R. M. Pope, and S. Shahrara. 2010. IL-17 contributes to angiogenesis in rheumatoid arthritis. J. Immunol. 184: 3233-3241.
13. Numasaki, M., J. Fukushi, M. Ono, S. K. Narula, P. J. Zavodny, T. Kudo, P. D. Robbins, H. Tahara, and M. T. Lotze. 2003. Interleukin-17 promotes angiogenesis and tumor growth. Blood 101: 2620-2627.
14. Cua, D. J., and C. M. Tato. 2010. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10: 479-489.
15. Liu, B., L. Wei, C. Meyerle, J. Tuo, H. N. Sen, Z. Li, S. Chakrabarty, E. Agron, C. C. Chan, M. L. Klein, et al. 2011. Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in agerelated macular degeneration. J. Transl. Med. 9: 1-12.
16. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387.
17. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748.
18. Krzystolik, M. G., M. A. Afshari, A. P. Adamis, J. Gaudreault, E. S. Gragoudas, N. A. Michaud, W. Li, E. Connolly, C. A. O'Neill, and J. W. Miller. 2002. Prevention of experimental choroidal neovascularization with intravitreal antivascular endothelial growth factor antibody fragment. Arch. Ophthalmol. 120: 338-346.
19. Oshima, Y., S. Oshima, H. Nambu, S. Kachi, K. Takahashi, N. Umeda, J. Shen, A. Dong, R. S. Apte, E. Duh, et al. 2005. Different effects of angiopoietin-2 in different vascular beds: new vessels are most sensitive. FASEB J. 19: 963-965.
20. Tanaka, K., K. Ichiyama, M. Hashimoto, H. Yoshida, T. Takimoto, G. Takaesu, T. Torisu, T. Hanada, H. Yasukawa, S. Fukuyama, et al. 2008. Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads. J. Immunol. 180: 3746-3756.
21. Shichita, T., Y. Sugiyama, H. Ooboshi, H. Sugimori, R. Nakagawa, I. Takada, T. Iwaki, Y. Okada, M. Iida, D. J. Cua, et al. 2009. Pivotal role of cerebral interleukin-17-producing gammadelta T cells in the delayed phase of ischemic brain injury. Nat. Med. 15: 946-950.
22. Michel, M. L., D. Mendes-da-Cruz, A. C. Keller, M. Lochner, E. Schneider, M. Dy, G. Eberl, and M. C. Leite-de-Moraes. 2008. Critical role of ROR-gt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc. Natl. Acad. Sci. USA 105: 19845-19850.
23. + T helper cells. Cell 126: 1121-1133.
24. Ichiyama, K., H. Yoshida, Y. Wakabayashi, T. Chinen, K. Saeki, M. Nakaya, G. Takaesu, S. Hori, A. Yoshimura, and T. Kobayashi. 2008. Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat. J. Biol. Chem. 283: 17003-17008.
25. Aggarwal, S., N. Ghilardi, M. H. Xie, F. J. de Sauvage, and A. L. Gurney. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278: 1910-1914.
26. Sutton, C. E., S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, and K. H. Mills. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
27. Wang, J., K. Ohno-Matsui, T. Yoshida, N. Shimada, S. Ichinose, T. Sato, M. Mochizuki, and I. Morita. 2009. Amyloid-beta up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: Another mechanism of complement activation in age-related macular degeneration. J. Cell. Physiol. 220: 119-128.
28. Su, Z., C. Sun, C. Zhou, Y. Liu, H. Zhu, S. Sandoghchian, D. Zheng, T. Peng, Y. Zhang, Z. Jiao, et al. 2011. HMGB1 blockade attenuates experimental autoimmune myocarditis and suppresses Th17-cell expansion. Eur. J. Immunol. 41: 3586-3595.
29. Lin, Q., X. P. Yang, D. Fang, X. Ren, H. Zhou, J. Fang, X. Liu, S. Zhou, F. Wen, X. Yao, et al. 2011. High-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesis. Arterioscler. Thromb. Vasc. Biol. 31: 1024-1032.
30. Degryse, B., T. Bonaldi, P. Scaffidi, S. Müller, M. Resnati, F. Sanvito, G. Arrigoni, and M. E. Bianchi. 2001. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152: 1197-1206.
31. Arimura, N., Y. Ki-i, T. Hashiguchi, K. Kawahara, K. K. Biswas, M. Nakamura, Y. Sonoda, K. Yamakiri, A. Okubo, T. Sakamoto, and I. Maruyama. 2009. Intraocular expression and release of high-mobility group box 1 protein in retinal detachment. Lab. Invest. 89: 278-289.
32. Martin, B., K. Hirota, D. J. Cua, B. Stockinger, and M. Veldhoen. 2009. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31: 321-330.
33. Ryan, S. J. 1979. The development of an experimental model of subretinal neovascularization in disciform macular degeneration. Trans. Am. Ophthalmol. Soc. 77: 707-745.
34. Takeda, A., J. Z. Baffi, M. E. Kleinman, W. G. Cho, M. Nozaki, K. Yamada, H. Kaneko, R. J. Albuquerque, S. Dridi, K. Saito, et al. 2009. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 460: 225-230.
35. Han, G., S. Geng, Y. Li, G. Chen, R. Wang, X. Li, Y. Ma, B. Shen, and Y. Li. 2011. gdT-cell function in sepsis is modulated by C5a receptor signalling. Immunology 133: 340-349.
36. Buonocore, S., P. P. Ahern, H. H. Uhlig, I. I. Ivanov, D. R. Littman, K. J. Maloy, and F. Powrie. 2010. Innate lymphoid cells drive interleukin-23- dependent innate intestinal pathology. Nature 464: 1371-1375.
37. Izcue, A., S. Hue, S. Buonocore, C. V. Arancibia-Cárcamo, P. P. Ahern, Y. Iwakura, K. J. Maloy, and F. Powrie. 2008. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 28: 559-570.
38. Fujimoto, T., K. H. Sonoda, K. Hijioka, K. Sato, A. Takeda, E. Hasegawa, Y. Oshima, and T. Ishibashi. 2010. Choroidal neovascularization enhanced by Chlamydia pneumoniae via Toll-like receptor 2 in the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 51: 4694-4702.
39. Yanai, H., T. Ban, Z. Wang, M. K. Choi, T. Kawamura, H. Negishi, M. Nakasato, Y. Lu, S. Hangai, R. Koshiba, et al. 2009. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462: 99-103.
40. Zhang, Q., M. Raoof, Y. Chen, Y. Sumi, T. Sursal, W. Junger, K. Brohi, K. Itagaki, and C. J. Hauser. 2010. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107.
41. Doyle, S. L., M. Campbell, E. Ozaki, R. G. Salomon, A. Mori, P. F. Kenna, G. J. Farrar, A. S. Kiang, M. M. Humphries, E. C. Lavelle, et al. 2012. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat. Med. 18: 791-798.
42. Shichita, T., E. Hasegawa, A. Kimura, R. Morita, R. Sakaguchi, I. Takada, T. Sekiya, H. Ooboshi, T. Kitazono, T. Yanagawa, et al. 2012. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat. Med. 18: 911-917.